St. Marien-Krankenhaus
Siegen, 57072, Germany
NCT Number: NCT03385109
An open label observational registry trial in which participating centers enroll subjects who had or will have a laparoscopically assisted surgery using the Senhance Surgical System.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Siegen, 57072, Germany
This is a prospective multi-center registry in which sites may also choose to retrospectively enroll subjects meeting the inclusion criteria, but whom have already been treated using the Senhance system. The data collection includes baseline patient characteristics, surgical details, and adverse events. Patient follow-up time point is open to the clinical practice of each center and only adverse events are tracked post discharge.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Patients are approached surgically with the Senhance Surgical System
Time frame: Surgery to 30 days post op
Any untoward sign symptom or disease
Asensus Surgical
Industry
The TransEnterix European Patient Registry for Robotic Assisted Laparoscopic Procedures in Urology, Abdominal Surgery, Thoracic and Gynecologic Surgery
Acronym: TRUST
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05735847
Arthritis, Joint Diseases
Hvidovre, Denmark
View Trial DetailsNCT04926220
Blood Pressure, Cardiac Output
Paris, France
View Trial DetailsNCT07081828
Surgery, Surgery in Early Childhood
München, Germany
View Trial DetailsNCT05454280
Cancer, Neoplasms
Philadelphia, Pennsylvania, United States
View Trial Details